233 related articles for article (PubMed ID: 11126389)
1. Neuroplasticity and cellular resilience in mood disorders.
Manji HK; Moore GJ; Rajkowska G; Chen G
Mol Psychiatry; 2000 Nov; 5(6):578-93. PubMed ID: 11126389
[TBL] [Abstract][Full Text] [Related]
2. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
3. Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.
Quiroz JA; Manji HK
Dialogues Clin Neurosci; 2002 Mar; 4(1):73-92. PubMed ID: 22034240
[TBL] [Abstract][Full Text] [Related]
4. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
Manji HK; Chen G
Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
[TBL] [Abstract][Full Text] [Related]
5. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
[TBL] [Abstract][Full Text] [Related]
7. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
Chen G; Huang LD; Zeng WZ; K Manji H
Int J Neuropsychopharmacol; 2001 Mar; 4(1):47-64. PubMed ID: 11343630
[TBL] [Abstract][Full Text] [Related]
8. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
9. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.
Du J; Quiroz JA; Gray NA; Szabo ST; Zarate CA; Manji HK
Dialogues Clin Neurosci; 2004 Jun; 6(2):143-55. PubMed ID: 22034247
[TBL] [Abstract][Full Text] [Related]
11. The underlying neurobiology of bipolar disorder.
Manji HK; Quiroz JA; Payne JL; Singh J; Lopes BP; Viegas JS; Zarate CA
World Psychiatry; 2003 Oct; 2(3):136-46. PubMed ID: 16946919
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
Bachmann RF; Schloesser RJ; Gould TD; Manji HK
Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281
[TBL] [Abstract][Full Text] [Related]
13. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
[TBL] [Abstract][Full Text] [Related]
14. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.
Carlson PJ; Singh JB; Zarate CA; Drevets WC; Manji HK
NeuroRx; 2006 Jan; 3(1):22-41. PubMed ID: 16490411
[TBL] [Abstract][Full Text] [Related]
15. Critical role of brain-derived neurotrophic factor in mood disorders.
Hashimoto K; Shimizu E; Iyo M
Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms in mood disorders: targeting neuroplasticity.
Fass DM; Schroeder FA; Perlis RH; Haggarty SJ
Neuroscience; 2014 Apr; 264():112-30. PubMed ID: 23376737
[TBL] [Abstract][Full Text] [Related]
17. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
18. Glutamate modulators as novel interventions for mood disorders.
Mathew SJ; Keegan K; Smith L
Braz J Psychiatry; 2005 Sep; 27(3):243-8. PubMed ID: 16224615
[TBL] [Abstract][Full Text] [Related]
19. Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.
Du J; Quiroz J; Yuan P; Zarate C; Manji HK
Neuron Glia Biol; 2004 Aug; 1(3):231-43. PubMed ID: 18634600
[TBL] [Abstract][Full Text] [Related]
20. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
